TTM
$3.42B
YoY change
+15.1%
5Y CAGR
+12.2%
Peak year (2025)
$3.05B
Cumulative gross profit
$29.55B
Gross Profit history chart for ResMed (RMD) from 1993 to 2025
Latest: $3.05B
Gross Profit growth chart for ResMed (RMD) from 1993 to 2025
Latest: +15.1%
Gross Profit history table for ResMed (RMD) from 1993 to 2025
| 2025 | $3.05B | +15.1% | +$399.67M | ||
| 2024 | $2.66B | +12.7% | +$299.64M | ||
| 2023 | $2.36B | +16.4% | +$331.35M | ||
| 2022 | $2.02B | +10.1% | +$185.21M | ||
| 2021 | $1.84B | +7.1% | +$121.31M | ||
| 2020 | $1.72B | +11.8% | +$181.20M | ||
| 2019 | $1.54B | +12.8% | +$174.42M | ||
| 2018 | $1.36B | +13.3% | +$160.42M | ||
| 2017 | $1.20B | +12.7% | +$135.25M | ||
| 2016 | $1.07B | +5.4% | +$55.10M | ||
| 2015 | $1.01B | +2.2% | +$21.61M | ||
| 2014 | $989.79M | +5.2% | +$49.13M | ||
| 2013 | $940.66M | +14.6% | +$119.92M | ||
| 2012 | $820.74M | +10.7% | +$79.41M | ||
| 2011 | $741.33M | +13.1% | +$85.84M | ||
| 2010 | $655.48M | +18.4% | +$101.68M | ||
| 2009 | $553.80M | +12.2% | +$60.05M | ||
| 2008 | $493.75M | +28.4% | +$109.26M | ||
| 2007 | $384.49M | +2.0% | +$7.60M | ||
| 2006 | $376.89M | +37.1% | +$102.03M | ||
| 2005 | $274.86M | +26.8% | +$58.12M | ||
| 2004 | $216.74M | +25.2% | +$43.65M | ||
| 2003 | $173.09M | +29.9% | +$39.84M | ||
| 2002 | $133.25M | +27.2% | +$28.47M | ||
| 2001 | $104.78M | +23.5% | +$19.91M | ||
| 2000 | $84.87M | +33.0% | +$21.07M | ||
| 1999 | $63.80M | +35.5% | +$16.70M | ||
| 1998 | $47.10M | +49.5% | +$15.60M | ||
| 1997 | $31.50M | +66.7% | +$12.60M | ||
| 1996 | $18.90M | +47.7% | +$6.10M | ||
| 1995 | $12.80M | +60.0% | +$4.80M | ||
| 1994 | $8.00M | +66.7% | +$3.20M | ||
| 1993 | $4.80M | — | — |
- 2025$3.05B+15.1%
- 2024$2.66B+12.7%
- 2023$2.36B+16.4%
- 2022$2.02B+10.1%
- 2021$1.84B+7.1%
- 2020$1.72B+11.8%
- 2019$1.54B+12.8%
- 2018$1.36B+13.3%
- 2017$1.20B+12.7%
- 2016$1.07B+5.4%
- 2015$1.01B+2.2%
- 2014$989.79M+5.2%
- 2013$940.66M+14.6%
- 2012$820.74M+10.7%
- 2011$741.33M+13.1%
- 2010$655.48M+18.4%
- 2009$553.80M+12.2%
- 2008$493.75M+28.4%
- 2007$384.49M+2.0%
- 2006$376.89M+37.1%
- 2005$274.86M+26.8%
- 2004$216.74M+25.2%
- 2003$173.09M+29.9%
- 2002$133.25M+27.2%
- 2001$104.78M+23.5%
- 2000$84.87M+33.0%
- 1999$63.80M+35.5%
- 1998$47.10M+49.5%
- 1997$31.50M+66.7%
- 1996$18.90M+47.7%
- 1995$12.80M+60.0%
- 1994$8.00M+66.7%
- 1993$4.80M—
Gross Profit values are taken from ResMed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current gross profit (TTM) is $3.42B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of ResMed (RMD) gross profit is $3.05B – grew 15.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed gross profit compounded at +12.2% per year, sustaining 32 straight years of year-over-year growth.
$3.05B stands as the all-time-high annual gross profit, posted in 2025, against a low of $4.80M during 1993.
ResMed Gross Profit by Year
ResMed Gross Profit 2025: $3.05B
ResMed posted gross profit of $3.05B in 2025, grew 15.1% from 2024. This figure represents the highest annual value in the available history.
ResMed Gross Profit 2024: $2.66B
In 2024, ResMed reported gross profit of $2.66B, grew 12.7% from 2023.
ResMed Gross Profit 2023: $2.36B
ResMed gross profit in 2023 was $2.36B, grew 16.4% from 2022.
ResMed Gross Profit 2022: $2.02B
2022's gross profit for ResMed came in at $2.02B, grew 10.1% from 2021.
ResMed Gross Profit 2021: $1.84B
ResMed gross profit in 2021 was $1.84B.
See more financial history for ResMed (RMD).
Sector peers by Gross Profit
Healthcare peers of ResMed (RMD), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation